Abraham A S
Department of Medicine, Shaare Zedek Medical Center, Jerusalem, Israel.
Magnes Trace Elem. 1990;9(4):177-85.
Acute myocardial infarction (AMI) accounts for a large number of deaths annually. The major cause of early deaths is ventricular fibrillation. During the past few years, intravenous magnesium has been instituted as a therapy for AMI. This report reviews the latter literature and discusses the potential mechanisms whereby intravenous Mg is beneficial in AMI. Intravenous Mg is a safe and inexpensive drug whose use reduces the incidence of arrhythmias, infarct size and early mortality following AMI.
急性心肌梗死（AMI）每年导致大量死亡。早期死亡的主要原因是心室颤动。在过去几年中，静脉注射镁已被用作治疗AMI的一种疗法。本报告回顾了相关文献，并讨论了静脉注射镁对AMI有益的潜在机制。静脉注射镁是一种安全且廉价的药物，其使用可降低AMI后心律失常的发生率、梗死面积和早期死亡率。
